Civic AI
Procurement intelligence
Federal contract award
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE CLIN0005/OPTION 4, UPDATE ARTICLES G.3 KEY PERSONNEL, G.4.G CONTRACT FINANCIAL REPORT, G.8 POST AWARD EVALUATION OF CONTRACTOR PERFORMANCE, CPARS POINT OF CONTACT, AND SECTION J, ATTACHMENT 1 STATEMENT
BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL · Department of Health and Human Services
- Value
- $39,762,216
- Start
- Sep 15, 2023
- End
- Dec 31, 2027
- Action date
- May 27, 2026
- PIID
- 75A50123C00050
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- MALVERN, PA
- Award type
- DEFINITIVE CONTRACT
Description
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE CLIN0005/OPTION 4, UPDATE ARTICLES G.3 KEY PERSONNEL, G.4.G CONTRACT FINANCIAL REPORT, G.8 POST AWARD EVALUATION OF CONTRACTOR PERFORMANCE, CPARS POINT OF CONTACT, AND SECTION J, ATTACHMENT 1 STATEMENT
Need modifications, related awards, and vendor peers? Open the full award workspace.